• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Virtual Specialty Care Company Summus Raises $19.5M and More Digital Health Fundings.

Share:

September 25, 2023

Virtual specialty care platform Summus has raised $19.5 million in funding, totaling $70 million raised to date. Summus focuses on providing virtual specialty care solutions to employers, health plans, hospitals, medical groups, and networks. The funds will be used to support the company’s growth and innovation. Additionally, healthy aging platform Bold has secured $17 million in Series A funding, bringing its total raised to $27 million. Bold partners with Medicare plans and providers to offer virtual exercise programs to prevent falls, increase physical activity, and reduce musculoskeletal issues among older adults.

Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.

Summus offers employers, health plans, hospitals and health systems, and medical groups and networks a virtual care platform focused on specialty care, including peer-to-peer solutions that allow primary care and in-plan specialist providers access to a specialist network.

The company will use the funds to scale its growth and innovation.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Last year, the New York-based company received a $22 million strategic investment from the Glenstone Foundation and Danaher Corporation’s cofounder and executive committee chairman Mitchell Rales.

It secured $21 million in a Series B round less than a year before.

Healthy aging platform Bold announced it secured $17 million in Series A funding led by Rethink Impact, bringing its total raise to $27 million.

Samsung Next participated in the round alongside existing investors Andreessen Horowitz (a16z) Bio + Health, Primetime Partners, GingerBread Capital and Khosla Ventures.

Jenny Abramson, founder and managing partner of Rethink Impact, will join Bold’s board of directors.

Bold partners with Medicare plans and providers to offer members virtual exercise programs aimed at preventing falls, increasing physical activity and reducing musculoskeletal pain and disability.

The funds will be used to grow the company’s exercise offerings and support its expansion with national and regional provider groups and Medicare plans.

“Bold is at the forefront of a new paradigm in preventive health care for older adults that is founded in deep empathy for members and a thorough understanding of cutting-edge health science,” Abramson said in a statement. “As the nation’s population continues to age and Medicare costs balloon, we desperately need innovative, evidence-based solutions like Bold that meet people where they are and drive value across the healthcare system, from members to providers to payers.”

Source: MobihealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • One-minute ’Game Changing’ COVID-19 Breath Test Currently Being Trialled in DubaiOne-minute ’Game Changing’ COVID-19 Breath Test Currently Being Trialled in Dubai
  • Were We Mentally Ready for COVID-19? Why It’s Time to Take Behavioral Health SeriouslyWere We Mentally Ready for COVID-19? Why It’s Time to Take Behavioral Health Seriously
  • Alto Neuroscience Uses AI to Create Biomarkers for Personalised Mental Health DrugsAlto Neuroscience Uses AI to Create Biomarkers for Personalised Mental Health Drugs
  • Baymatob Secures $3M Funding to Complete Its Pilot Study on AI Labour Monitoring DeviceBaymatob Secures $3M Funding to Complete Its Pilot Study on AI Labour Monitoring Device
  • C. Light Launches AI-Driven Retinal Eye-Tracking; Predicts Neurological Health in 10 SecondsC. Light Launches AI-Driven Retinal Eye-Tracking; Predicts Neurological Health in 10 Seconds
  • How Health Plans can Prepare Their Members for Coronavirus (COVID-19)How Health Plans can Prepare Their Members for Coronavirus (COVID-19)
  • Sarasota tech firm sells software unit for $925MSarasota tech firm sells software unit for $925M
  • Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen LogisticsCaprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications